MBIO
Mustang Bio Inc
NASDAQ: MBIO · HEALTHCARE · BIOTECHNOLOGY
$0.75
-0.66% today
Updated 2026-04-29
Market cap
$5.68M
P/E ratio
—
P/S ratio
2,205.73x
EPS (TTM)
$-0.39
Dividend yield
—
52W range
$1 – $4
Volume
0.0M
Mustang Bio Inc (MBIO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-1.57M | $-4.13M | $-12.95M | $-19.24M | $-33.58M | $-37.32M | $-53.67M | $-65.07M | $-49.48M | $-11.41M | $-5.26M |
| Capital expenditures | $424000.00 | $424000.00 | $2.80M | $7.95M | $3.69M | $4.41M | $5.37M | $3.08M | $114000.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | $2.01M | $4.96M | $2.66M | $2.99M | $3.31M | $2.28M | $568000.00 | $-450000.00 | $129000.00 |
| Free cash flow | $-2.00M | $-4.55M | $-15.75M | $-27.19M | $-37.28M | $-41.73M | $-59.03M | $-68.14M | $-49.59M | $-11.41M | $-5.26M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $0.00 | $320000.00 | — | — | — | — | — | $477000.00 | $611000.00 | $273000.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $27.50M | $7.98M | $-18.51M | $45.44M | $36.39M | — | — | — | — | — |